News mentioning PLUVICTO
38 stories
Sep 21, 26Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
Sep 21, 26Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
Aug 3, 26FDA expands Pluvicto label, making it available to most metastatic prostate cancer patients